Huang Zhen, Yan Hua, Chavan Devendra, Yuan Zeng, Yang Xingsheng, Zhang Youzhong, Song Kun, Kong Beihua
Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China.
Department of Spleen and Stomach Diseases, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250012, P.R. China.
Oncol Lett. 2018 Jan;15(1):588-591. doi: 10.3892/ol.2017.7285. Epub 2017 Oct 30.
The present case report describes a patient with stage IV ovarian cancer who survived for 9 years without achieving a complete remission since the first relapse. The patient's long-term survival may be ascribed to the slow growth of the cancer cells, limited metastasis and favorable responses to the treatments received. The patient manifested initially with malignant pleural effusion and was not able to tolerate surgical treatment. However, the disease was well-controlled using various treatments, including neoadjuvant chemotherapy, interval cytoreductive surgery and post-operative long-term chemotherapy. Management of ovarian cancer is most effective when tailored to the individual needs of the patient, maximizing its efficacy and prolonging the patient's survival rate. The present case may offer useful insight into the clinical management of stage IV ovarian cancer.
本病例报告描述了一名IV期卵巢癌患者,自首次复发后存活了9年,未实现完全缓解。患者的长期存活可能归因于癌细胞生长缓慢、转移有限以及对所接受治疗的良好反应。患者最初表现为恶性胸腔积液,无法耐受手术治疗。然而,通过包括新辅助化疗、间隔减瘤手术和术后长期化疗在内的各种治疗,病情得到了良好控制。卵巢癌的治疗根据患者的个体需求进行定制时最为有效,可最大限度地提高疗效并延长患者的生存率。本病例可能为IV期卵巢癌的临床管理提供有用的见解。